Necrotizing sialometaplasia (NS) is a nonneoplastic inflammatory condition of the salivary glands. In 1973, Abrams et al first reported this condition. The clinical and histopathologic features of necrotizing sialometaplasia often simulate those of malignancies such as squamous cell carcinoma or salivary gland malignancy. All subsequent reports of necrotizing sialometaplasia stress the importance of correct diagnosis. Familiarity with necrotizing sialometaplasia and correct diagnosis are paramount in avoiding misdiagnosis and inappropriate treatment. Ischemia of salivary gland tissue leading to infarction (trauma) is the most likely cause.
A related Medscape Reference article that may be of interest is Cancers of the Oral Mucosa.
Necrotizing sialometaplasia was first reported to involve the minor salivary glands of the oral cavity, particularly those of the palate. Seventy-five percent of all cases occur on the posterior palate. Most are unilateral, with one third occurring in a bilateral or midpalatal location. Reports of this entity in the minor glands of the retromolar pad area, buccal mucosa, tongue, incisive canal, and labial mucosa followed. In addition, necrotizing sialometaplasia is recognized in the parotid and submandibular salivary glands, minor mucous glands in the lung, nasal cavity,[6, 7] larynx,[8, 9] trachea, nasopharynx, and maxillary sinus. Similar lesions are identified in the breast; the condition is referred to as posttraumatic lobular metaplasia of the breast.
Mesa and colleagues reported an incidence of 0.03% based on findings in 10,000 oral biopsy specimens. However, they state that this percentage does not account for cases of necrotizing sialometaplasia that heal spontaneously without biopsy.
Necrotizing sialometaplasia is reported worldwide. Isolated cases and reviews from Europe, North America, South America, and Asia are reported in the literature.
The lesions of necrotizing sialometaplasia often are painless; less frequently, they cause pain and numbness. The clinical appearance that suggests cancer is the significant feature of this lesion. The clinical pictures show a patient with a lesion thought to be cancer who underwent biopsy and was monitored for 9 weeks. Over that time, regression of the lesion can be seen (see the images below).
Three weeks later after biopsy.
At 6 weeks.
Nine weeks. Salivary gland infarction.
Brannon and colleagues reported that cases of necrotizing sialometaplasia in whites outnumbered cases in blacks by a ratio of 4.9:1. Given the ratio of whites to blacks in the United States, a significant racial predilection does not appear to exist.
The male-to-female ratio is approximately 2:1.
The average age of patients with necrotizing sialometaplasia in the Armed Forces Institute of Pathology (AFIP) registry is 47.9 years, with a range of 17-80 years. The average age is 43.1 years for female patients and 50.3 years for male patients. A case of necrotizing sialometaplasia in an 18-month-old infant is reported.
Most cases of necrotizing sialometaplasia appear to arise spontaneously, whereas others are associated with a history of trauma, vomiting,[15, 16] radiation therapy, or surgery. An association with neoplasia, such as parotid tumors, false vocal cord squamous cell carcinoma, and maxillary sinus carcinoma, is also reported. Cases associated with inflammatory conditions such as relapsing polychondritis and acute and chronic sinusitis have been noted to occur in the subglottic and sinus regions, respectively.
Necrotizing sialometaplasia manifests as a swelling with or without ulceration in anatomic sites that have mucous or serous glandular tissue.
The typical clinical presentation of necrotizing sialometaplasia is that of a crateriform ulcer of the palate that simulates a malignant process. These ulcerated lesions are 1-3 cm and are usually unilateral, but bilateral synchronous lesions and metachronous lesions can occur.[17, 18, 19]
Some lesions of necrotizing sialometaplasia may present as a submucosal swelling, without ulceration of the overlying mucosa. An intact surface mucosa may be noted in an evolving lesion at the time of diagnosis, although most cases are accompanied by mucosal ulceration. Erosion of the palatal bone may occur in either ulcerated or nonulcerated lesions.
Examination of a biopsy specimen is usually required to establish the correct diagnosis and to exclude a malignant or infectious process or an inflammatory condition such as Wegener granulomatosis. Extranodal lymphoma also may be considered in the clinical differential diagnosis of a palatal swelling or ulceration.
In most cases of necrotizing sialometaplasia, the etiology is believed to be related to vascular ischemia. Cases are reported in which vascular compression is caused by a necrotic myocutaneous reconstruction flap, embolization from carotid endarterectomy, sickle cell anemia, Buerger disease, or Raynaud phenomenon.
The association of adjacent neoplasia that results in ischemic necrosis of the glandular elements and the histologic features of necrotizing sialometaplasia supports this pathogenic mechanism. In an experimental study in a rat model, local anesthetic injections induced necrotizing sialometaplasia. Tobacco use is suggested as a possible etiologic risk factor for necrotizing sialometaplasia.
A definitive tissue diagnosis of necrotizing sialometaplasia should exclude the need for radiographic imaging. If erosion of the palatal bone occurs with or without perforation, radiologic examination may be performed.
Incisional biopsy is necessary to establish the diagnosis of necrotizing sialometaplasia (NS). An inadequate biopsy specimen may lead to the misdiagnosis of squamous cell carcinoma or mucoepidermoid carcinoma. Findings in a superficial or limited biopsy specimen may be misinterpreted as a nonspecific ulcer or pseudoepitheliomatous hyperplasia of the surface mucosa.
The microscopic features of necrotizing sialometaplasia include coagulative necrosis of glandular acini and squamous metaplasia of its ducts. Mucin pooling is present, and an associated inflammatory infiltrate consists of macrophages; neutrophils; and, less commonly, lymphocytes, plasma cells, and eosinophils.
Pseudoepitheliomatous hyperplasia of the overlying mucosa can also be present, but the cytologic features of the squamous component are usually bland. Occasionally, isolated mucous cells may be entrapped within the squamous islands; these cells should not be confused with those of mucoepidermoid carcinoma.
The microscopic differential diagnosis for necrotizing sialometaplasia includes mucoepidermoid carcinoma and squamous cell carcinoma. Some believe that subacute necrotizing sialadenitis is yet another entity that occurs within the spectrum of necrotizing sialometaplasia; it should be distinguished from necrotizing sialometaplasia.
Necrotizing sialometaplasia (NS) resolves spontaneously. No treatment is necessary.
Surgical care for necrotizing sialometaplasia consists of incisional biopsy for diagnostic purposes.
Periodic evaluation of the affected site is recommended until spontaneous resolution occurs.
The prognosis for necrotizing sialometaplasia (NS) is excellent. Spontaneous resolution usually occurs within weeks, although in the case presented, the lesion took more than 9 weeks to reach complete healing.
The average healing time for necrotizing sialometaplasia of the minor salivary glands of the hard and soft palates is approximately 5 weeks. The size of the lesion and whether or not bony perforation has occurred are clinical parameters that may influence the healing time.